Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;42(4):e15520.
doi: 10.1111/dme.15520. Epub 2025 Feb 3.

Consistency of the personalized glycated haemoglobin (pHbA1c) methodology over time in people with type 1 diabetes (T1D) using continuous glucose monitoring

Adrian H Heald  1   2 , Mike Stedman  3 , Angela Paisley  2 , Edward Jude  4 , Hellena Habte-Asres  5 , J Martin Gibson  1   2 , Angus Forbes  5 , Martin Whyte  6
Affiliations

Consistency of the personalized glycated haemoglobin (pHbA1c) methodology over time in people with type 1 diabetes (T1D) using continuous glucose monitoring

Adrian H Heald et al. Diabet Med. 2025 Apr.
No abstract available

Keywords: HbA1c; T1D; glycation; personalised HbA1c.

PubMed Disclaimer

Conflict of interest statement

None of the co‐authors have any conflict of interest.

Figures

FIGURE 1
FIGURE 1
Comparing ratio of pHbA1c to Lab HbA1c (as %) between first HbA1c sample and second HbA1c sample for the same patient (N = total days between sample dates). Personal HbA1c (pHbA1c) calculated from average taken from CGM in period (given N days) prior to blood samples compared to laboratory labHbA1c.
See this image and copyright information in PMC

References

    1. Gebel E. The start of something good: the discovery of HbA(1c) and the American Diabetes Association Samuel Rahbar Outstanding Discovery Award. Diabetes Care. 2012;35(12):2429‐2431. - PMC - PubMed
    1. UK Prospective Diabetes Study (UKPDS) Group . Intensive blood‐glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837‐853. - PubMed
    1. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10‐year follow‐up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577‐1589. - PubMed
    1. Nathan DM, DCCT/EDIC Research Group . The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study at 30 years: overview. Diabetes Care. 2014;37:9‐16. - PMC - PubMed
    1. Beltran Del Rio M, Tiwari M, Amodu LI, et al. Glycated hemoglobin, plasma glucose, and erythrocyte aging. J Diabetes Sci Technol. 2016;10(6):1303‐1307. - PMC - PubMed

LinkOut - more resources